- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medipharm Labs Corp (LABS)
The Medipharm share price today is 0.09, view TSX LABS stock exchange data. Track the latest Medipharm share price with real-time updates on LABS stock performance including market cap, day range, 52-week range and dividend yield. Access LABS charts, earnings dates and analyst estimates to support your investment decisions.
0.09
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.09
0.09
52 wk Range
0.06
0.11
Earnings results expected in 14 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.090.09
52 wk Range
0.060.11
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LABS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
0.00
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- MediPharm responds to Apollo allegations
- Investing.com
- Apollo Capital releases MediPharm activist plan
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.00
Medipharm Labs Corp Earnings Call Summary for Q4/2025
- Q4 revenue reached CAD 14.06M, beating forecasts by 5.79%; EPS matched expectations at zero, driving 7.69% pre-market stock surge.
- Full-year revenue grew 8% YoY to highest in five years; net loss improved 22.4% to CAD 8.3M through disciplined cost management.
- International medical cannabis now exceeds 50% of total revenue, reflecting strategic shift to higher-margin products and markets.
- Company maintains strong cash position with no material debt; Q4 gross margin reached 35% on CAD 3.9M gross profit.
- 2026 priorities include expanding EU GMP Napanee facility capacity and increasing shipments to France and Brazil markets.
Last Updated: 27-04-2026, 07:28 pm
Read Full TranscriptEarnings
Latest Release
30-03-2026
EPS / Forecast
-- / -0.00
Revenue / Forecast
14.06M / 13.29M
Compare LABS to Peers and Sector
Metrics to compare | LABS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLABSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.6x | −2.0x | −0.5x | |
PEG Ratio | −0.19 | 0.00 | 0.00 | |
Price/Book | 1.1x | 0.6x | 2.6x | |
Price / LTM Sales | 0.8x | 0.7x | 3.2x | |
Upside (Analyst Target) | - | 61.4% | 48.1% | |
Fair Value Upside | Unlock | 24.6% | 6.6% | Unlock |
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
FAQ
What Is the Medipharm (LABS) Share Price Today?
The Medipharm share price today is 0.09.
What is the current Medipharm (LABS) share price and day range?
As of 04-05-2026, the Medipharm share price is 0.09, with a previous close of 0.09. The share price has ranged from 0.09 to 0.09 today, while the 52-week range spans from 0.06 to 0.11.
What Is the Medipharm Market Cap?
As of today, Medipharm market cap is 38.24M.
What Is Medipharm's Earnings Per Share (TTM)?
The Medipharm EPS (TTM) is -0.02.
When Is the Next Medipharm Earnings Date?
Medipharm will release its next earnings report on 18-05-2026.
From a Technical Analysis Perspective, Is LABS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Medipharm Trade On?
Medipharm is listed and trades on the Toronto Stock Exchange.
What Is the Stock Symbol for Medipharm?
The stock symbol for Medipharm is "LABS."
How Many Times Has Medipharm Stock Split?
Medipharm has split 1 times.
How Many Employees Does Medipharm Have?
Medipharm has 127 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.